1380 related articles for article (PubMed ID: 11015608)
1. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
[TBL] [Abstract][Full Text] [Related]
2. iNOS expression in dystrophinopathies can be reduced by somatic gene transfer of dystrophin or utrophin.
Louboutin JP; Rouger K; Tinsley JM; Halldorson J; Wilson JM
Mol Med; 2001 May; 7(5):355-64. PubMed ID: 11474581
[TBL] [Abstract][Full Text] [Related]
3. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
[TBL] [Abstract][Full Text] [Related]
4. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer.
Cerletti M; Negri T; Cozzi F; Colpo R; Andreetta F; Croci D; Davies KE; Cornelio F; Pozza O; Karpati G; Gilbert R; Mora M
Gene Ther; 2003 May; 10(9):750-7. PubMed ID: 12704413
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated utrophin gene transfer mitigates the dystrophic phenotype of mdx mouse muscles.
Gilbert R; Nalbantoglu J; Petrof BJ; Ebihara S; Guibinga GH; Tinsley JM; Kamen A; Massie B; Davies KE; Karpati G
Hum Gene Ther; 1999 May; 10(8):1299-310. PubMed ID: 10365661
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 6 induces overexpression of the sarcolemmal utrophin in neonatal mdx skeletal muscle.
Fujimori K; Itoh Y; Yamamoto K; Miyagoe-Suzuki Y; Yuasa K; Yoshizaki K; Yamamoto H; Takeda S
Hum Gene Ther; 2002 Mar; 13(4):509-18. PubMed ID: 11874629
[TBL] [Abstract][Full Text] [Related]
7. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
8. Forced myofiber regeneration promotes dystrophin gene transfer and improved muscle function despite advanced disease in old dystrophic mice.
Guibinga GH; Ebihara S; Nalbantoglu J; Holland P; Karpati G; Petrof BJ
Mol Ther; 2001 Nov; 4(5):499-507. PubMed ID: 11708887
[TBL] [Abstract][Full Text] [Related]
9. Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice.
Deconinck N; Tinsley J; De Backer F; Fisher R; Kahn D; Phelps S; Davies K; Gillis JM
Nat Med; 1997 Nov; 3(11):1216-21. PubMed ID: 9359695
[TBL] [Abstract][Full Text] [Related]
10. Efficient utrophin expression following adenovirus gene transfer in dystrophic muscle.
Gilbert R; Nalbanoglu J; Tinsley JM; Massie B; Davies KE; Karpati G
Biochem Biophys Res Commun; 1998 Jan; 242(1):244-7. PubMed ID: 9439643
[TBL] [Abstract][Full Text] [Related]
11. [Utrophin, a way to cure Duchenne muscle dystrophy].
Gillis JM
Med Sci (Paris); 2004 Apr; 20(4):442-7. PubMed ID: 15124117
[TBL] [Abstract][Full Text] [Related]
12. Sustained improvement of muscle function one year after full-length dystrophin gene transfer into mdx mice by a gutted helper-dependent adenoviral vector.
Dudley RW; Lu Y; Gilbert R; Matecki S; Nalbantoglu J; Petrof BJ; Karpati G
Hum Gene Ther; 2004 Feb; 15(2):145-56. PubMed ID: 14975187
[TBL] [Abstract][Full Text] [Related]
13. Gene transfer studies in animals: what do they really tell us about the prospects for gene therapy in DMD?
Wells DJ; Wells KE
Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S11-22. PubMed ID: 12206790
[TBL] [Abstract][Full Text] [Related]
14. Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models.
Song Y; Morales L; Malik AS; Mead AF; Greer CD; Mitchell MA; Petrov MT; Su LT; Choi ME; Rosenblum ST; Lu X; VanBelzen DJ; Krishnankutty RK; Balzer FJ; Loro E; French R; Propert KJ; Zhou S; Kozyak BW; Nghiem PP; Khurana TS; Kornegay JN; Stedman HH
Nat Med; 2019 Oct; 25(10):1505-1511. PubMed ID: 31591596
[TBL] [Abstract][Full Text] [Related]
15. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice.
Rafael JA; Tinsley JM; Potter AC; Deconinck AE; Davies KE
Nat Genet; 1998 May; 19(1):79-82. PubMed ID: 9590295
[TBL] [Abstract][Full Text] [Related]
17. Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene.
Wakefield PM; Tinsley JM; Wood MJ; Gilbert R; Karpati G; Davies KE
Gene Ther; 2000 Feb; 7(3):201-4. PubMed ID: 10694796
[TBL] [Abstract][Full Text] [Related]
18. An attempt of gene therapy in Duchenne muscular dystrophy: overexpression of utrophin in transgenic mdx mice.
Gillis JM
Acta Neurol Belg; 2000 Sep; 100(3):146-50. PubMed ID: 11098286
[TBL] [Abstract][Full Text] [Related]
19. Expression of full-length utrophin prevents muscular dystrophy in mdx mice.
Tinsley J; Deconinck N; Fisher R; Kahn D; Phelps S; Gillis JM; Davies K
Nat Med; 1998 Dec; 4(12):1441-4. PubMed ID: 9846586
[TBL] [Abstract][Full Text] [Related]
20. The role of utrophin in the potential therapy of Duchenne muscular dystrophy.
Perkins KJ; Davies KE
Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S78-89. PubMed ID: 12206801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
